CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single and multi-organ microphysiological systems (MPS), today announced that
CN Bio’s PhysioMimix™ adopted by King’s College London to investigate chronic liver disease
Home »
Coffee Could Be the Secret Weapon Against NAFLD
Treatment of obesity through exercise and diet is unquestionably the foundation of care for patients with nonalcoholic fatty liver disease
WHA’s president outlines plans to improve treatments for patients with hepatitis
Danjuma Adda, a Nigerian public health expert, became the president-elect of the World Hepatitis Alliance (WHA) in November last year.
Interactions between bacteria and parasites: Blood flukes and Helicobacter pylori: co-infection changes immune response
A team at the Technical University of Munich (TUM) has completed the first study of the effects of a simultaneous
Lab-on-a-chip may help identify new treatments for liver disease
Non-alcoholic fatty liver disease (NAFLD) — the accumulation of liver fat in people who drink little or no alcohol —
Hepatitis B: Unusual virus discovered in shrews
The discovery of an unusual hepatitis B virus from shrews offers new opportunities of better understanding the chronic progression of
Drug sponge could minimize side effects of cancer treatment: Absorbent polymer sops up chemotherapy drugs from bloodstream after treatment
With the help of sponges inserted in the bloodstream to absorb excess drugs, doctors are hoping to prevent the dangerous
New study evaluates efficacy of PET imaging to manage chronic liver diseases
While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications. These effects may
Losing just six hours of sleep could increase diabetes risk, study finds: Sleep deprivation alters liver metabolism and fat content
Losing a single night’s sleep may affect the liver’s ability to produce glucose and process insulin, increasing the risk of
Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased